CO.DON AG
CO.DON AG: Positive opinion from CHMP for EU approval of articular cartilage product
CO.DON AG / Key word(s): Market launch CO.DON AG (ISIN: DE DE000A1K0227) Positive opinion from CHMP for EU approval of articular cartilage product Berlin / Teltow, 18 May 2017 – In the course of the ongoing application for EU marketing authorisation CO.DON AG received today the official positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its articular cartilage product. The recommended indication is the repair of symptomatic articular cartilage defects on the femoral condyle and the knee patella; defects of up to 10 cm² for adults. Further information: Matthias Meißner, M.A. Investor relations
18-May-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | CO.DON AG |
Warthestraße 21 | |
14513 Teltow | |
Germany | |
Phone: | 03328 43460 |
Fax: | 03328 434643 |
E-mail: | info@codon.de |
Internet: | www.codon.de |
ISIN: | DE000A1K0227 |
WKN: | A1K022 |
Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange |
End of Announcement | DGAP News Service |